We are live on ! Find out more
DnB Asset Management

DnB Asset Management Portfolio holdings

AUM $28B
1-Year Est. Return 26%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+26%
3 Year Est. Return
+97.1%
5 Year Est. Return
+115.87%
10 Year Est. Return
+443.63%
AUM
$21B
AUM Growth
+$1.78B
Cap. Flow
+$810M
Cap. Flow %
3.86%
Top 10 Hldgs %
41.71%
Holding
734
New
29
Increased
533
Reduced
117
Closed
26

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$387M
2
CRM icon
Salesforce
CRM
+$129M
3
AAPL icon
Apple
AAPL
+$113M
4
INTC icon
Intel
INTC
+$108M
5
DDOG icon
Datadog
DDOG
+$97.6M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$408M
2
QCOM icon
Qualcomm
QCOM
+$231M
3
NVDA icon
NVIDIA
NVDA
+$91.8M
4
ORCL icon
Oracle
ORCL
+$60M
5
SWKS icon
Skyworks Solutions
SWKS
+$54.7M

Sector Composition

Rank Sector Weight
1 Technology 36.18%
2 Communication Services 16.48%
3 Financials 11.98%
4 Healthcare 9.31%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
626
Cytokinetics
CYTK
$11B
$392K ﹤0.01%
7,231
+645
+10% +$38.9K
NIO icon
627
NIO
NIO
$11.3B
$389K ﹤0.01%
93,584
– –
DM
628
DELISTED
Desktop Metal, Inc.
DM
$378K ﹤0.01%
91,420
+38,832
+74% +$266K
TAL icon
629
TAL Education Group
TAL
$5.71B
$346K ﹤0.01%
32,385
-106,742
-77% -$1.26M
HIMS icon
630
Hims & Hers Health
HIMS
$6.5B
$337K ﹤0.01%
16,696
-797
-5% -$13.3K
BZ icon
631
Kanzhun
BZ
$6.89B
$330K ﹤0.01%
17,544
+3,123
+22% +$62.9K
MLTX icon
632
MoonLake Immunotherapeutics
MLTX
$1.59B
$324K ﹤0.01%
7,372
+1,694
+30% +$71.8K
PI icon
633
Impinj
PI
$3.89B
$321K ﹤0.01%
+2,046
New +$304K
FOLD
634
DELISTED
Amicus Therapeutics
FOLD
$319K ﹤0.01%
32,183
+5,165
+19% +$53K
APLS
635
DELISTED
Apellis Pharmaceuticals
APLS
$306K ﹤0.01%
7,972
+1,904
+31% +$86.2K
CLDX icon
636
Celldex Therapeutics
CLDX
$2.77B
$292K ﹤0.01%
7,872
+2,523
+47% +$95.2K
BHVN icon
637
Biohaven
BHVN
$2.16B
$285K ﹤0.01%
+8,220
New +$325K
RDW icon
638
Redwire
RDW
$2.08B
$280K ﹤0.01%
39,094
+7,538
+24% +$36.3K
IMVT icon
639
Immunovant
IMVT
$8.09B
$271K ﹤0.01%
10,290
+958
+10% +$27.2K
SNDX icon
640
Syndax Pharmaceuticals
SNDX
$1.84B
$270K ﹤0.01%
13,172
+3,804
+41% +$79.6K
GD icon
641
General Dynamics
GD
$105B
$265K ﹤0.01%
+915
New +$268K
PSX icon
642
Phillips 66
PSX
$82.9B
$249K ﹤0.01%
+1,764
New +$261K
RXRX icon
643
Recursion Pharmaceuticals
RXRX
$1.57B
$248K ﹤0.01%
+33,119
New +$289K
MORF
644
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$245K ﹤0.01%
7,202
+614
+9% +$18.2K
IMCR icon
645
Immunocore
IMCR
$1.78B
$244K ﹤0.01%
7,211
+1,868
+35% +$95.3K
MPC icon
646
Marathon Petroleum
MPC
$90.3B
$240K ﹤0.01%
+1,386
New +$258K
STEM icon
647
Stem
STEM
$49.2M
$232K ﹤0.01%
10,464
+3,918
+60% +$115K
ZWS icon
648
Zurn Elkay Water Solutions
ZWS
$8.07B
$229K ﹤0.01%
7,781
– –
ANNX icon
649
Annexon
ANNX
$855M
$228K ﹤0.01%
46,485
+10,574
+29% +$54.7K
NCLH icon
650
Norwegian Cruise Line
NCLH
$8.89B
$226K ﹤0.01%
+12,000
New +$211K
24 25
26
27 28

Similar funds

N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

DnB Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, DnB Asset Management held 734 positions worth $21B, up 9.3% from $19.2B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

DnB Asset Management deployed $810M of net new capital in Q2 2024, opening 29 new positions and adding to 533 existing holdings. Its largest new stake was Viking Holdings: 1,467,660 shares worth $49.9M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $408M trimmed.

  • DnB Asset Management's largest Q2 2024 buy was Viking Holdings: 1,467,660 shares worth $49.9M.
  • DnB Asset Management added most to Amazon in Q2 2024, an estimated $387M increase.
  • DnB Asset Management's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $408M.
  • DnB Asset Management fully exited Alibaba in Q2 2024, selling an estimated $27.1M.
  • DnB Asset Management's ten largest holdings make up 42% of its $21B portfolio in Q2 2024.
  • DnB Asset Management opened 29 new positions and closed 26 in Q2 2024.
  • DnB Asset Management's portfolio value rose 9.3% quarter-over-quarter to $21B.

Based on DnB Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.